LEMAITRE VASCULAR INC (LMAT) Forecast, Price Target & Analyst Ratings

NASDAQ:LMAT • US5255582018

Current stock price

112.23 USD
+1.48 (+1.34%)
At close:
112.23 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for LEMAITRE VASCULAR INC (LMAT).

Forecast Snapshot

Consensus Price Target

Price Target
$105.74
-5.78% Downside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 29, 2026
Period
Q1 / 2026
EPS Estimate
$0.67
Revenue Estimate
67.739M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
78.82%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$105.74
Upside
-5.78%
From current price of $112.23 to mean target of $105.74, Based on 17 analyst forecasts
Low
$87.87
Median
$110.16
High
$126.00

Price Target Revisions

1 Month
0.00%
3 Months
-0.64%

Price Target Summary

17 Wall Street analysts provided a forecast for the next 12 months for LMAT. The average price target is 105.74 USD. This implies a price decrease of -5.78% is expected in the next year compared to the current price of 112.23.
The average price target has been revised downward by 0.64% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

LMAT Current Analyst RatingLMAT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

LMAT Historical Analyst RatingsLMAT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
78.82%
LMAT was analyzed by 17 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about LMAT.
In the previous month the buy percentage consensus was at a similar level.
LMAT was analyzed by 17 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-26CitizensMaintains Market Outperform -> Market Outperform
2026-02-26Barrington ResearchMaintains Outperform -> Outperform
2026-02-26Wells FargoMaintains Equal-Weight -> Equal-Weight
2026-02-26Roth CapitalReiterate Buy -> Buy
2026-02-20Barrington ResearchMaintains Outperform -> Outperform
2025-11-07Wells FargoMaintains Equal-Weight -> Equal-Weight
2025-11-05Roth CapitalReiterate Buy
2025-10-15Barrington ResearchMaintains Outperform -> Outperform
2025-09-23Barrington ResearchMaintains Outperform -> Outperform
2025-08-06Cantor FitzgeraldMaintains Neutral -> Neutral
2025-08-06Barrington ResearchUpgrade Market Perform -> Outperform
2025-07-22Barrington ResearchReiterate Market Perform -> Market Perform
2025-02-28Citizens Capital MarketsMaintains Buy -> Buy
2025-02-28Lake StreetMaintains Buy -> Buy
2025-02-28Barrington ResearchDowngrade Outperform -> Market Perform
2025-02-13Wells FargoInitiate Equal-Weight
2024-11-01Barrington ResearchMaintains Outperform -> Outperform
2024-11-01OppenheimerReiterate Outperform -> Outperform
2024-10-15Cantor FitzgeraldInitiate Neutral
2024-09-20Barrington ResearchMaintains Outperform -> Outperform
2024-08-20JMP SecuritiesMaintains Market Outperform -> Market Outperform
2024-08-02Barrington ResearchMaintains Outperform -> Outperform
2024-05-31Roth MKMReiterate Buy
2024-05-03Barrington ResearchMaintains Outperform -> Outperform
2024-05-03JMP SecuritiesMaintains Market Outperform -> Market Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 29, 2026
Period
Q1 / 2026
EPS Estimate
$0.67
Revenue Estimate
67.739M
Revenue Q2Q
13.14%
EPS Q2Q
40.25%
Number of Analysts
11

Next Earnings Revisions

Revenue (1 Month)
0.92%
Revenue (3 Months)
0.92%
EPS (1 Month)
7.10%
EPS (3 Months)
7.10%

Next Earnings Summary

LMAT is expected to report earnings on 4/29/2026. The consensus EPS estimate for the next earnings is 0.67 USD and the consensus revenue estimate is 67.74M USD.
The next earnings revenue estimate has been revised upward by 0.92% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
LMAT revenue by date.LMAT revenue by date.
193.484M
19.66%		219.863M
13.63%		249.602M
13.53%		283.7M
13.66%		309.15M
8.97%		337.4M
9.14%		365.39M
8.30%		401.27M
9.82%		437.38M
9.00%		476.75M
9.00%
EBITDA
YoY % growth
LMAT ebitda by date.LMAT ebitda by date.
46.712M
18.77%		61.926M
32.57%		78.33M
26.49%		92.44M
18.01%		102.84M
11.25%		114.96M
11.79%		124.75M
8.52%		N/AN/AN/A
EBIT
YoY % growth
LMAT ebit by date.LMAT ebit by date.
37.197M
24.40%		52.256M
40.48%		67.912M
29.96%		72.98M
7.46%		82.854M
13.53%		90.923M
9.74%		106.01M
16.59%		109.75M
3.53%		121.79M
10.97%		135.15M
10.97%
Operating Margin
LMAT operating margin by date.LMAT operating margin by date.
19.22%23.77%27.21%25.72%26.80%26.95%29.01%27.35%27.85%28.35%
EPS
YoY % growth
LMAT eps by date.LMAT eps by date.
1.34
44.09%		1.94
44.78%		2.38
22.68%		2.88
20.86%		3.17
10.09%		3.42
8.12%		3.66
6.95%		N/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		0.67
40.25%		0.75
25.18%		0.65
4.67%		0.68
0.69%		0.61
-9.09%		0.70
-6.30%		0.67
3.73%		0.73
7.26%
Revenue
Q2Q % growth		67.739M
13.14%		72.119M
12.28%		67.908M
11.24%		70.476M
9.34%		N/AN/AN/AN/A
EBITDA
Q2Q % growth		21.009M
38.42%		23.831M
11.66%		22.309M
-20.68%		22.757M
-22.20%		N/AN/AN/AN/A
EBIT
Q2Q % growth		17.567M
39.13%		20.124M
24.67%		17.868M
-12.03%		18.968M
0.72%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

LMAT Yearly Revenue VS EstimatesLMAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M
LMAT Yearly EPS VS EstimatesLMAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
12.89%
EPS Next 5 Year
11.37%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
10.08%
Revenue Next 5 Year
9.67%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
19.89%
EBIT Next 5 Year
16.94%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

LEMAITRE VASCULAR INC / LMAT Forecast FAQ

What is the price target for LMAT stock?

17 analysts have analysed LMAT and the average price target is 105.74 USD. This implies a price decrease of -5.78% is expected in the next year compared to the current price of 112.23.

When does LEMAITRE VASCULAR INC (LMAT) report earnings?

LEMAITRE VASCULAR INC (LMAT) will report earnings on 2026-04-29.

What are the consensus estimates for LEMAITRE VASCULAR INC (LMAT) next earnings?

The consensus EPS estimate for the next earnings of LEMAITRE VASCULAR INC (LMAT) is 0.67 USD and the consensus revenue estimate is 67.74M USD.

What is the consensus rating for LEMAITRE VASCULAR INC (LMAT) stock?

The consensus rating for LEMAITRE VASCULAR INC (LMAT) is 78.8235 / 100 . This indicates that analysts generally have a positive outlook on the stock.